U.S. Hepatorenal Syndrome Treatment Market to Reach $2.29 Billion by 2027 at a CAGR of 14.78% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hepatorenal Syndrome Treatment Market Research Report by Type (Type 1 Hepatorenal Syndrome and Type 2 Hepatorenal Syndrome), Treatment, End-User, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Hepatorenal Syndrome Treatment Market size was estimated at USD 1,004.79 million in … [Read more…]